Home sunrisefpau Novartis set to buy Avidity Biosciences for more than $10bn Novartis set to buy Avidity Biosciences for more than $10bn Author - Financial Adviser Melbourne October 26, 2025 0 Deal would be biggest acquisition under chief executive Vas Narasimhan International homepage Tags sunrisefpau Facebook Twitter Whatsapp Newer Older
